Posts Tagged ‘drug importation’
Connecticut Bioscience Growth Council ED explains why drug importation is “unworkable.”
In this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
[...]Canadian drug importation – What’s the state of the issue in June 2021?
What’s happening with Canadian drug importation? What’s Florida doing with a big empty warehouse? Isn’t this policy currently in the courts? You’ve got questions and we’ve got answers.
[...]An Analysis Of New Mexico’s Draft Canadian Drug Importation Plan
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…
[...]There is no Way to Regulate the Quality of Drugs Imported by American Patients
This editorial by Brandon Macsata was published in The International Business Times on November 1, 2020. Macsata has been living with HIV since 2002, and serves as the CEO of the ADAP Advocacy Association, an organization that promotes the AIDS Drug Assistance Program and works to improve access to care.
[...]“…barriers will delay or prevent drug importation,” say regulatory experts
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
[...]Newspaper Editorial Board Says Canadian Drug Importation Will Have Limited Impact
The editorial board of the Florida Times-Union published an op-ed that states that Canadian drug importation will have a limited impact, and is a sign of a broken system, not a solution to one…
[...]Wyoming’s Dept. of Health Recommends The State Not Attempt A Drug Importation Program
Wyoming is one of many states that decided to examine if importing drugs would provide significant savings to its citizens. In a hearing in August and a report released today, they took a critical look at the issue and the Department of Health recommends that the state not pursue the idea for several key reasons…
[...]HHS Secretary Sent Congress The Certification To Allow Canadian Drug Importation
On September 23, 2020, Department of Health and Human Services Alex Azar submitted a letter to House Minority Leader Kevin McCarthy certifying that Canadian drug importation would pose not additional threats to consumers and would save Americans a significant amount of money on prescription drugs.
[...]“These drugs would go through additional shipping, inspection and repackaging. Why would they be cheaper?”
In this editorial, which was published in WBUR’s Cognoscenti on September 2, 2020, writer Sarah Ruth Bates explains why Canadian drug importation is too expensive and elaborate a solution to be effective.
[...]Counterfeit Medicine News for the Week of August 3, 2020
In PSM’s round-up this week: COVID-19 fraud, a new DEA initiative to slow the sale of pill presses, and ongoing counterfeit pill news—including charges filed in the death of L.A. Angels pitcher Tyler Skaggs.
[...]